# Intersect ENT, Inc. – FDA Inspection, Nov 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/intersect-ent-inc/7aa084f2-49b8-4d49-a997-31e51bf7de64
Source feed: FDA_Inspections

> FDA inspection 1030747 of Intersect ENT, Inc., November 03, 2017. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030747
- Company Name: Intersect ENT, Inc.
- Inspection Date: 2017-11-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1282446 - 2025-08-07](https://www.keypedia.com/records/fda_inspections/intersect-ent-inc/cb9709fc-a6ec-483e-a4d7-a2c95f5805b5)
- [FDA Inspection 1082757 - 2019-03-06](https://www.keypedia.com/records/fda_inspections/intersect-ent-inc/386c875d-d441-4fb6-9f72-4d5f937ca0e2)
- FDA Inspection 1009402 - 2017-04-06
- [FDA Inspection 883393 - 2014-06-27](https://www.keypedia.com/records/fda_inspections/intersect-ent-inc/a0290201-2ee3-4ac1-8c2a-ff650b4df790)
- FDA Inspection 809111 - 2012-12-11

## Related Officers

- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/lucila-b-nwatu/3d1c9670-8206-425c-bddd-32e395293042)

Company: https://www.keypedia.com/companies/intersect-ent-inc/4b6941c3-1d67-4c6e-8f2b-febe75f3f7dc

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df